Fred Alger Management’s Meridian Bioscience Inc VIVO Stock Holding History

Fred Alger Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-619,293	Closed	-$8.86M	–	603
2017 Q3	$8.86M	Sell	619,293 -1,298	-0.2%	-$18.5K	0.04%	190
2017 Q2	$9.77M	Buy	620,591 +2,200	+0.4%	+$31.7K	0.05%	177
2017 Q1	$8.53M	Buy	618,391 +230,642	+59%	+$3.23M	0.04%	186
2016 Q4	$6.86M	Buy	387,749 +74,388	+24%	+$1.31M	0.04%	171
2016 Q3	$6.04M	Buy	313,361 +32,283	+11%	+$632K	0.03%	195
2016 Q2	$5.48M	Buy	281,078 +57,338	+26%	+$1.12M	0.03%	202
2016 Q1	$4.61M	Buy	+223,740	New	+$4.41M	0.02%	264
2015 Q2	–	Sell	-113,678	Closed	-$2.17M	–	551
2015 Q1	$2.17M	Buy	+113,678	New	+$2.1M	0.01%	428

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Fred Alger Management's VIVO Position: Q4 2017 in Review

Fred Alger Management sold out of Meridian Bioscience Inc (VIVO) in Q4 2017, closing a stake of 619,293 shares — an estimated $8.86M sold.

Fred Alger Management first reported a position in VIVO in Q1 2015 and held it in 8 quarters. The position peaked at $9.77M in Q2 2017. 178 funds tracked by Wall St. Rank hold VIVO as of Q4 2017.

Fred Alger Management reported no remaining Meridian Bioscience Inc position as of Q4 2017 after selling out during the quarter.
Fred Alger Management sold 619,293 Meridian Bioscience Inc shares in Q4 2017, an estimated $8.86M.
Fred Alger Management first reported a position in Meridian Bioscience Inc in Q1 2015 and held it in 8 quarters.
Fred Alger Management's Meridian Bioscience Inc position peaked at $9.77M in Q2 2017.
178 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2017.

Based on Fred Alger Management's 13F filing for Q4 2017, filed 14 Feb 2018.